RA CAPITAL MANAGEMENT, L.P. received a stock award from JANUX THERAPEUTICS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 6/13/2025ACC: 0001415889-25-017318
Director10% Owner
Since Jun 2021
+15.42K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
15.42K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+3.75K
Price / share
—
Trade value
—
% of position
150.0%
6/11/2025
2.50K→6.25K
Total
Net shares
+3.75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 6/11/2025 | A · Award | +3.75K | — | — | 150.0% | 2.50K | 6.25K |
| Total | +3.75K | $0.00 | ||||||
Derivative Transactions1
Stock Option (Right to Buy)
Indirect
Converts to
Common Stock
11.67K shares
Shares
+11.67K
Strike price
25.46
Held after
11.67K
Exercisable
—
6/11/2025
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) Indirect | Common Stock11.67K shares | 6/11/2025 | A · Award | +11.67K | 25.46 | — | 11.67K |
Non-Derivative Holdings (Post-Transaction)2
Common Stock
IndirectShares owned10.14M
Common Stock
IndirectShares owned1.05M
Total
11.19M indirect11.19M
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 10.14M | Indirect |
| Common Stock | 1.05M | Indirect |
| Total | 11.19M | 11.19M indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported